1. microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway
   Yuan Chi et al, 2022, Cell Cycle CrossRef
2. Role of EphA2‑PI3K signaling in vasculogenic mimicry induced by cancer‑associated fibroblasts in gastric cancer cells
   Hee Kim et al, 2019, Oncology Letters CrossRef
3. Pre-Exposure to Stress-Inducing Agents Increase the Anticancer Efficacy of Focused Ultrasound against Aggressive Prostate Cancer Cells
   Hakm Y. Murad et al, 2022, Antioxidants CrossRef
4. Expression and role of VEGFA and miR‑381 in portal vein tumor thrombi in patients with hepatocellular carcinoma
   Jing Wang et al, 2018, Experimental and Therapeutic Medicine CrossRef
5. Targeting HIF-2α as therapy for advanced cancers
   Thanabal Murugesan et al, 2018, Drug Discovery Today CrossRef
6. Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner
   Hea Nam Hong et al, 2018, Journal of Cancer Research and Clinical Oncology CrossRef
7. How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles
   Yan Fu et al, 2023, Cancers CrossRef
8. Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
   Chunying Xiao et al, 2023, Frontiers in Pharmacology CrossRef
9. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivo
   Lun Wu et al, 2021, Pathology - Research and Practice CrossRef